Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America

American Journal of Medicine

Volumn 107, Issue 1 A, 1999, Pages 28-33

  Barry, Arthur L ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; AZLOCILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; IMIPENEM; KETOLIDE; LORACARBEF; MACROLIDE; MEROPENEM; MEZLOCILLIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN; UNINDEXED DRUG;

BACTERIUM ISOLATE; CONFERENCE PAPER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0033606825     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00102-3     Document Type: Conference Paper

References (50)

1. Austrian R. Pneumococcus the first one hundred years . Rev Infect Dis. 3:1981;183-189.
2. Hamburger M., Schmidt L.H., Sesler C., et al. The occurrence of sulfonamide-resistant pneumococci in clinical practice. J Infect Dis. 73:1943;12-30.
3. Evans W., Hansman D. Tetracycline-resistant pneumococci. Lancet. i:1963;451.
4. Turner G.C. Tetracycline-resistant pneumococci in a general hospital. Lancet. ii:1963;1292-1295.
5. Dixon J.M.S. Pneumococcus resistant to erythromycin and lincomycin. Lancet. i:1967;573.
6. Cybulska J., Jeljaszewicz J., Lund E., et al. Prevalence of types of Diplococcus pneumoniae and their susceptibility to 35 antibiotics. Chemotherapy. 15:1970;304-316.
7. Hansman D. Chloramphenicol-resistant pneumococci in West Africa. Lancet. i:1978;1102-1103.
8. Hansman D., Bullen M.M. A resistant pneumococcus. Lancet. ii:1967;264-265.
9. Hansman D., Glasgow H., Sturt J., et al. Increased resistance to penicillin of pneumococci isolated from man. N Engl J Med. 284:1971;175-177.
10. Hansman D., Devitt L., Miles H., et al. Pneumococci relatively insensitive to penicillin in Australia and New Guinea. Med J Aust. ii:1974;353-356.
11. Appelbaum P.C., Bhamjee A., Scragg J.N., et al. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet. ii:1997;995-997.
12. Jacobs M.R., Koornhof H.J., Robins-Browne R.M., et al. Emergence of multiply resistant pneumococci. N Engl J Med. 299:1978;735-740.
13. Kristinsson K.G. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist. 3:1997;117-123.
14. Appelbaum P.C. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol. 6:1987;367-377.
15. Klugman K.P. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 3:1990;171-196.
16. Hoberman A., Paradise J.L., Block S., et al. Efficacy of amoxicillin/clavulanate for acute otitis media relation to Streptococcus pneumoniae susceptibility . Pediatr Infect Dis J. 15:1996;955.
17. Jacobs M.R. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis. 15:1992;119-127.
18. Paredes A., Taber L.H., Yow M.D., et al. Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics. 58:1976;378-381.
19. Ward J.I., Koornhof H., Jacobs M., et al. Clinical and epidemiological features of multiply resistant pneumococci, South Africa. Schlessinger D. Microbiology 1979 . 1979;283-285 American Society for Microbiology, Washington, DC.
20. Ward J. Antibiotic-resistant Streptococcus pneumoniae clinical and epidemiological aspects . Rev Infect Dis. 3:1981;254-266.
21. Doern G.V., Brueggemann A.B., Pierce G. Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 16:1997;311-314.
22. Barry A.L., Pfaller M.A., Fuchs P.C., et al. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory tract pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother. 38:1994;2419-2425.
23. Cooksey R.C., Facklam R.R., Thornsberry C. Antimicrobial susceptibility patterns of Streptococcus pneumoniae. Antimicrob Agents Chemother. 13:1978;645-648.
24. Spika J.S., Facklam R.R., Plikaytis B.D., et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States 1979-1987. J Infect Dis. 163:1991;1273-1278.
25. Jorgensen J.H., Doern G.V., Maher L.A., et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 34:1990;2075-2080.
26. Thornsberry C., Brown S.D., Yee C., et al. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Infect Med. 93:(suppl):1993;15-24.
27. Barry A.L., Fuchs P.C., Brown S.D. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from outpatients in the U.S.A. J Antimicrob Chemother. 40:1997;139-140.
28. Doern G.V., Brueggemann A., Holley H.P., et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995 results of a 30-center national surveillance study . Antimicrob Agents Chemother. 40:1996;1208-1213.
29. Barry A.L., Brown S.D., Fuchs P.C. Fluoroquinolone resistance among recent isolates of Streptococcus pneumoniae. J Antimicrob Chemother. 43:1999;428-429.
30. Simor A.E., Louie M., Low D.E. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 40:1996;2190-2193.
31. Simor A.E., Louie L., Goodfellow M., et al. Emergence of penicillin-resistant Streptococcus pneumoniae - southern Ontario, Canada, 1993-1994. MMWR. 44:1996;207-208.
32. Laible G., Hackenbeck R. Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniae. J Bacteriol. 173:1991;6986-6990.
33. Markiewicz Z., Tomasz A. Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. J Clin Microbiol. 27:1989;405-410.
34. Linares J., Alonso T., Perez J.L., et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother. 30:1992;279-288.
35. Spangler S.K., Jacobs M.R., Appelbaum P.C. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrob Agents Chemother. 38:1994;898-900.
36. Barry A.L., Brown S.D., Novick W.J. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob Agents Chemother. 39:1995;2193-2196.
37. Bradley J.S., Conner J.D. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 10:1991;871-873.
38. McDougal L.K., Facklam R., Reeves M., et al. Analyses of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother. 36:1992;2176-2184.
39. Henderson F.W., Gilligan P.H., Wait K., Goss D.A. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis. 157:1988;256-263.
40. Radetsky M.S., Istre G.R., Johansen T.L., et al. Multiply resistant pneumococcus causing meningitis its epidemiology within a day care center . Lancet. 2:1981;771-773.
41. Leclercq R., Courvalin P. Resistance to macrolides, azalides and streptogramins. Neu H.C., Young S.S., Zinner S.H. The New Macrolides, Azalides and Streptogramins Pharmacology and Clinical Applications . 1993;33-40 Marcel Dekker, New York.
42. Shortridge V.D., Flamm R.K., Ramer N., et al. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis. 26:1996;73-78.
43. Sutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin a common pattern mediated by an efflux system . Antimicrob Agents Chemother. 40:1996;1817-1824.
44. Barry A.L., Fuchs P.C., Brown S.D. In vitro activity of the new ketolide HMR 3001 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 16:1997;767-769.
45. Barry A.L., Fuchs P.C., Brown S.D. Antipneumococcal activity of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin) and a lincosamide (clindamycin). Antimicrob Agents Chemother. 42:1998;945-946.
46. Janoir C., Zellar V., Kitzis M.D., et al. High level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in par C and gyr A. Antimicrob Agents Chemother. 40:1996;2760-2764.
47. Perez-Trallero E., Garcia-Arenzana J.M., Jimenex J.A., et al. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur J Clin Microbiol Infect Dis. 9:1990;905-906.
48. Tankovic J., Perichon B., Duval J., et al. Contribution of mutations in gyr A and par C genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob Agents Chemother. 40:1996;2505-2510.
49. Brueggemann A.B., Kugler K.C., Doern G.V. In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Antimicrob Agents Chemother. 41:1997;1594-1597.
50. Cooper B., Lawler M. Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia. Am J Med. 87:1989;475.